Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.290
-0.160 (-6.53%)
At close: May 2, 2024, 4:00 PM
2.270
-0.020 (-0.87%)
After-hours: May 2, 2024, 6:02 PM EDT

bioAffinity Technologies Revenue

In the year 2023, bioAffinity Technologies had annual revenue of $2.53M with 52,627.44% growth. Revenue in the quarter ending December 31, 2023 was $2.21M with 94,245.95% year-over-year growth.

Revenue (ttm)
$2.53M
Revenue Growth
+52,627.44%
P/S Ratio
10.41
Revenue / Employee
$180,893
Employees
14
Market Cap
26.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 20210--
Dec 31, 20200--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BIAF News

More News